|Coordinate||25,051,563 bp (GRCm38)|
|Base Change||A ⇒ G (forward strand)|
|Gene Name||dedicator of cytokinesis 8|
|Synonym(s)||A130095G14Rik, 5830472H07Rik, 1200017A24Rik|
|Chromosomal Location||24,999,529-25,202,432 bp (+)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the DOCK180 family of guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with Rho GTPases and are components of intracellular signaling networks. Mutations in this gene result in the autosomal recessive form of the hyper-IgE syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Jun 2010]
PHENOTYPE: Mice homozygous for inactivating mutations of this gene exhibit loss of marginal zone B cells, decrease in peritoneal B1 cells and peripheral naive T cells, failure of sustained antibody response after immunization, failure of germinal center persistence, and failure of B cell affinity maturation. [provided by MGI curators]
|Amino Acid Change||Threonine changed to Alanine|
|Institutional Source||Beutler Lab|
|Gene Model||predicted gene model for protein(s): [ENSMUSP00000025831]|
AA Change: T44A
|Predicted Effect||probably benign
PolyPhen 2 Score 0.002 (Sensitivity: 0.99; Specificity: 0.30)
|Meta Mutation Damage Score||0.178|
|Is this an essential gene?||Probably nonessential (E-score: 0.095)|
|Candidate Explorer Status||CE: excellent candidate; human score: 2; ML prob: 0.76|
Linkage Analysis Data
|Alleles Listed at MGI|
|Mode of Inheritance||Unknown|
|Last Updated||2019-09-04 9:31 PM by Diantha La Vine|
|Record Created||2019-01-22 11:02 AM by Bruce Beutler|
The Defenseless phenotype was identified among G3 mice of the pedigree R1633, some of which showed reduced frequencies of CD8+ T cells in the peripheral blood (Figure 1).
|Nature of Mutation|
Whole exome HiSeq sequencing of the G1 grandsire identified 63 mutations. The reduced CD8+ T cell frequency phenotype was linked by continuous variable mapping to a mutation in Dock8: an A to G transition at base pair 25,051,563 (v38) on chromosome 19, or base pair 52,053 in the GenBank genomic region NC_000085 encoding the Dock8 gene. Linkage was found with a dominant model of inheritance, wherein one variant homozygote and eight heterozygous mice departed phenotypically from nine homozygous reference mice with a P value of 0.000763 (Figure 2).
The mutation corresponds to residue 252 in the mRNA sequence NM_028785 within exon 2 of 48 total exons.
The mutated nucleotide is indicated in red. The mutation results in a threonine to alanine substitution at position 44 (T44A) in the DOCK8 protein, and is strongly predicted by Polyphen-2 to be benign (score = 0.002).
DOCK8 belongs to the DOCK180 superfamily of guanine nucleotide exchange factors (GEFs) that have been shown to activate members of the Rho family of small GTPases (1-4). The DOCK C subfamily (which includes DOCK8 and DOCK7; see the record for moonlight) has dual specificity for Rac and Cdc42 (1;3;5;6). Two domains are shared amongst all DOCK proteins, the catalytic DHR-2 (DOCK homology region 2) or CZH-2 (CDM-zizimin homology 2) domain and the DHR-1 or CZH-1 domain (Figure 3). The DHR-1 domain is located N-terminal to the DHR-2 domain (2;4).
The Defenseless mutation results in a threonine to alanine substitution at position 44 (T44A). Thr44 is within an undefined region preceding the DHR-1 domain.
Please see the record for captain morgan for more information on Dock8.
The Rho GTPases are known regulators of the actin cytoskeleton and affect multiple cellular activities including cell morphology, polarity, migration, proliferation and apoptosis, phagocytosis, cytokinesis, adhesion, vesicular transport, transcription and neurite extension and retraction. Like DOCK2, DOCK8 is likely to regulate the activity of GTPases and thus be involved in cytoskeletal changes associated with various cellular processes. DOCK8 is proposed to serve as an effector downstream of CD19 and PI3K to promote G protein signaling events critical for integrin polarization at the synapse and for the survival of marginal zone B cells and germinal center (GC) B cells.
During a T cell-dependent humoral immune response, CD4+ T helper cell subsets including TFH, Th1 and Th2 cells migrate to the T cell/B cell borders in SLO, and interact with cognate antigen-specific B cells through the pairing of T cell and B cell surface ligands and receptors such as CD40 with its ligand (see the record for walla). This interaction results in the secretion by T helper cells of certain cytokines known to promote B cell survival, proliferation, and antibody production (7;8).
In humans, DOCK8 deficiency results in an autosomal recessive form of hyper-IgE recurrent infection syndrome (HIES; OMIM #243700) (9;10). Autosomal dominant HIES is characterized by recurrent Staphylococcus aureus skin abscesses, increased serum IgE, and abnormalities of the connective tissue, skeleton, and dentition (11). The autosomal recessive form shares hyper-IgE, eosinophilia, and recurrent Staphylococcal infections, but is distinguished from autosomal dominant HIES by the lack of connective tissue and skeletal involvement (12). Patients with DOCK8 deficiency are unusually susceptible to viral infections and virally-caused cancers. Reduced numbers of T, B, and NK cells have been reported along with a selective defect in CD8+ T cell activation (9). However, another study suggests most patients have normal numbers of B and NK cells, a greater decrease in the CD4+ T cell population than the CD8+ T cell population, and a more comprehensive T cell activation defect involving both T cell subsets (10). Both autosomal dominant and autosomal recessive HIES are linked to a lack of Th17 cell function including the failure to produce the interleukin 17 (IL-17) cytokine (12). Th17 are a subset of CD4+ T helper cells that play an important role in the development of autoimmune diseases like rheumatoid arthritis, as well as being critical in the clearance of fungal and extracellular bacterial infections (13).
The relatively normal initiation of antibody production by mice with Dock8 mutations suggests that the extrafollicular B cell clonal expansion, plasma cell formation and immunoglobulin class switching, which depends on interactions with T helper cells, is intact. However, subsequent antibody responses and affinity maturation occurring in the GCs is significantly impaired. The humoral deficits are due to a defect in GC B cell survival and selection during the affinity maturation phase of GC responses (14).
The phenotype of the Defenseless mice indicates loss of DOCK8-associated function.
Defenseless(F):5'- TGGAAGTGCTCTGCTCACAACTC -3'
Defenseless(R):5'- CTGGGCTGTCTCATTCTATACACGC -3'
Defenseless_seq(F):5'- TCTGCTCACAACTCAGCCAAG -3'
Defenseless_seq(R):5'- TCATTCTATACACGCCAGAGGG -3'
1) 94°C 2:00
The following sequence of 400 nucleotides is amplified (chromosome 19, + strand):
1 tggaagtgct ctgctcacaa ctcagccaag aactgcgttg ggattatagt gtgttgggtt
Primer binding sites are underlined and the sequencing primers are highlighted; the mutated nucleotide is shown in red.
1. Cote, J. F., and Vuori, K. (2002) Identification of an Evolutionarily Conserved Superfamily of DOCK180-Related Proteins with Guanine Nucleotide Exchange Activity. J Cell Sci. 115, 4901-4913.
2. Cote, J. F., and Vuori, K. (2007) GEF what? Dock180 and Related Proteins Help Rac to Polarize Cells in New Ways. Trends Cell Biol. 17, 383-393.
3. Meller, N., Irani-Tehrani, M., Kiosses, W. B., Del Pozo, M. A., and Schwartz, M. A. (2002) Zizimin1, a Novel Cdc42 Activator, Reveals a New GEF Domain for Rho Proteins. Nat Cell Biol. 4, 639-647.
4. Meller, N., Irani-Tehrani, M., Ratnikov, B. I., Paschal, B. M., and Schwartz, M. A. (2004) The Novel Cdc42 Guanine Nucleotide Exchange Factor, zizimin1, Dimerizes Via the Cdc42-Binding CZH2 Domain. J Biol Chem. 279, 37470-37476.
5. Brugnera, E., Haney, L., Grimsley, C., Lu, M., Walk, S. F., Tosello-Trampont, A. C., Macara, I. G., Madhani, H., Fink, G. R., and Ravichandran, K. S. (2002) Unconventional Rac-GEF Activity is Mediated through the Dock180-ELMO Complex. Nat Cell Biol. 4, 574-582.
6. Miyamoto, Y., Yamauchi, J., Sanbe, A., and Tanoue, A. (2007) Dock6, a Dock-C Subfamily Guanine Nucleotide Exchanger, has the Dual Specificity for Rac1 and Cdc42 and Regulates Neurite Outgrowth. Exp Cell Res. 313, 791-804.
7. MacLennan, I. C., Toellner, K. M., Cunningham, A. F., Serre, K., Sze, D. M., Zuniga, E., Cook, M. C., and Vinuesa, C. G. (2003) Extrafollicular Antibody Responses. Immunol Rev. 194, 8-18.
8. King, C., Tangye, S. G., and Mackay, C. R. (2008) T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune Responses. Annu Rev Immunol. 26, 741-766.
9. Zhang, Q., Davis, J. C., Lamborn, I. T., Freeman, A. F., Jing, H., Favreau, A. J., Matthews, H. F., Davis, J., Turner, M. L., Uzel, G., Holland, S. M., and Su, H. C. (2009) Combined Immunodeficiency Associated with DOCK8 Mutations. N Engl J Med. 361, 2046-2055.
10. Engelhardt, K. R., McGhee, S., Winkler, S., Sassi, A., Woellner, C., Lopez-Herrera, G., Chen, A., Kim, H. S., Lloret, M. G., Schulze, I., Ehl, S., Thiel, J., Pfeifer, D., Veelken, H., Niehues, T., Siepermann, K., Weinspach, S., Reisli, I., Keles, S., Genel, F., Kutukculer, N., Camcioglu, Y., Somer, A., Karakoc-Aydiner, E., Barlan, I., Gennery, A., Metin, A., Degerliyurt, A., Pietrogrande, M. C., Yeganeh, M., Baz, Z., Al-Tamemi, S., Klein, C., Puck, J. M., Holland, S. M., McCabe, E. R., Grimbacher, B., and Chatila, T. A. (2009) Large Deletions and Point Mutations Involving the Dedicator of Cytokinesis 8 (DOCK8) in the Autosomal-Recessive Form of Hyper-IgE Syndrome. J Allergy Clin Immunol. 124, 1289-302.e4.
11. Grimbacher, B., Holland, S. M., Gallin, J. I., Greenberg, F., Hill, S. C., Malech, H. L., Miller, J. A., O'Connell, A. C., and Puck, J. M. (1999) Hyper-IgE Syndrome with Recurrent Infections--an Autosomal Dominant Multisystem Disorder. N Engl J Med. 340, 692-702.
12. Renner, E. D., Puck, J. M., Holland, S. M., Schmitt, M., Weiss, M., Frosch, M., Bergmann, M., Davis, J., Belohradsky, B. H., and Grimbacher, B. (2004) Autosomal Recessive Hyperimmunoglobulin E Syndrome: A Distinct Disease Entity. J Pediatr. 144, 93-99.
13. Weaver, C. T., Hatton, R. D., Mangan, P. R., and Harrington, L. E. (2007) IL-17 Family Cytokines and the Expanding Diversity of Effector T Cell Lineages. Annu Rev Immunol. 25, 821-852.
14. Randall, K. L., Lambe, T., Johnson, A. L., Treanor, B., Kucharska, E., Domaschenz, H., Whittle, B., Tze, L. E., Enders, A., Crockford, T. L., Bouriez-Jones, T., Alston, D., Cyster, J. G., Lenardo, M. J., Mackay, F., Deenick, E. K., Tangye, S. G., Chan, T. D., Camidge, T., Brink, R., Vinuesa, C. G., Batista, F. D., Cornall, R. J., and Goodnow, C. C. (2009) Dock8 Mutations Cripple B Cell Immunological Synapses, Germinal Centers and Long-Lived Antibody Production. Nat Immunol. 10, 1283-1291.
|Science Writers||Anne Murray|
|Illustrators||Diantha La Vine|
|Authors||Xue Zhong, Jin Huk Choi, and Bruce Beutler|